The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

With enough supplies, Israel looks to re-route AstraZeneca vaccine delivery

Wed, 21st Apr 2021 10:45

* Israel bought enough vaccine from others, official says

* Seeks to divert AstraZeneca shipment to other countries

* Israel's vaccine rollout one of the fastest in the world

JERUSALEM, April 21 (Reuters) - Israel no longer wants
AstraZeneca's COVID-19 vaccine and is exploring with the
company whether a big shipment in the pipeline could be sent
elsewhere, Israel's pandemic coordinator said on Wednesday.

"We are trying to find the best solution. After all, we
don't want (the vaccines) to get here and have to throw them
into the trash," the official, Nachman Ash, told Army Radio,
saying Israel's needs were being met by other suppliers.

In his remarks, Ash made no reference to AstraZeneca’s
vaccine having been associated with very rare blood clots in
Europe. Many countries there resumed administering it after the
European Union's drug watchdog said benefits outweighed risks.

Israel cast a wide net last year when trying to secure
vaccine doses at the height of the pandemic and pre-ordered from
a number of companies.

It largely settled on the Pfizer/BioNTech
vaccine, launching one of the world's swiftest rollouts.
COVID-19 infections in Israel have dropped dramatically and the
economy has reopened.

Israel is also buying the COVID-19 vaccines from Moderna
, which uses a similar messenger RNA (mRNA) technology.

Ash said that with supplies secure through 2022, Israel no
longer required the 10 million doses it agreed to purchase from
AstraZeneca.

"They can certainly be used in other places in the world. At
the moment, we are trying to find, along with the company, the
best way to do this," he said.

"We believe it would be best if they (the vaccines) did not
come to Israel and we agree with the company on some sort of way
to divert them elsewhere."

Officials at AstraZeneca had no immediate comment.

Around 81% of Israeli citizens or residents over 16 - the
age group eligible for the Pfizer/BioNTech vaccine in Israel -
have received both doses.

Some 167,000 of the 5.2 million Palestinians in the occupied
West Bank and Islamist Hamas-run Gaza have had at least one dose
of vaccine, with supplies coming in from Israel, Russia, the
United Arab Emirates, the global COVAX vaccine-sharing programme
and China.
(Reporting by Jeffrey Heller and Ari Rabinovitch. Editing by
Mark Potter)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.